A spin-out from the Center for Inverse Problems, Imaging and Tomography, TechniScan Medical Systems (TMS) is a privately held medical device company engaged in the development and commercialization of a revolutionary ultrasound imaging system, UltraSound CTTM (USCTTM). TMS’ imaging system is designed to provide physicians with a new, non-invasive, diagnostic imaging tool that will provide detailed information about the anatomy (i.e. physical structures within the breast) and pathology (i.e. bulk tissue properties). The system is intended to be used as an adjunct to mammography to aid physicians in diagnosing breast cancer by characterizing the ultrasound properties of normal, benign and malignant tissues in the breast.

Company News

Techniscan was founded in 1984 by Principal Investigator Steven A. Johnson, Ph.D. and four partners. The company is still in development and is prerevenue. Techniscan has raised over $14 million in private equity and an additional $10 million in federal funding. The company currently has 15 full time employees with an average salary around $85,000.

Highlights

• TechniScan received top honors in the Medical Device category of the third annual Stoel Rives Utah Innovation Awards in 2005
• National Cancer Institute Awards TechniScan $2.8 million Grant, the largest for a private company in Utah.

• UltraSound CT (USCT)

• 15 FTEs with an average salary of $85,000
• Raised $14M in private equity and $10M federal funding